Capital International’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.88M Sell
19,011
-8,582
-31% -$2.94M 0.22% 93
2026
Q1
$9.71M Buy
27,593
+344
+1% +$123K 0.36% 76
2025
Q4
$8.92M Sell
27,249
-28,564
-51% -$9.06M 0.31% 81
2025
Q3
$15.8M Buy
55,813
+25,071
+82% +$7.27M 0.57% 50
2025
Q2
$8.58M Hold
30,742
0.33% 79
2025
Q1
$9.58M Buy
+30,742
New +$9.08M 0.42% 69

Other funds holding AMGN

Capital International's AMGN Position: Q2 2026 in Review

Capital International reduced its Amgen (AMGN) stake by 31% in Q2 2026, selling an estimated $2.94M and leaving 19,011 shares worth $6.88M. The position accounts for 0.22% of the portfolio, ranked #93.

Capital International first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $15.8M in Q3 2025. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Capital International held 19,011 shares of Amgen worth $6.88M as of Q2 2026.
  • Capital International sold 8,582 Amgen shares in Q2 2026, an estimated $2.94M.
  • Amgen made up 0.22% of Capital International's portfolio in Q2 2026, its #93 holding.
  • Capital International first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • Capital International's Amgen position peaked at $15.8M in Q3 2025.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Capital International's 13F filing for Q2 2026, filed 12 Aug 2026.